Nonetheless, numerous challenges remain
Science 320 , 7782 (2008)
Key Findings The results demonstrated that Wegovy HD 7.2mg delivered significant weight loss: Average weight loss of approximately 20.7% after 72 weeks Greater average weight loss compared with the standard 2.4mg dose More than one-third of participants lost at least 25% of their starting body weight More than 90% of participants achieved at least 5% weight loss These findings suggest that higher-dose semaglutide may offer an effective option for patients who require additional support to achieve meaningful weight reduction
Therefore, plateaus can be normal, and progress can still be real
[DOI] [PMC free article] [PubMed] [Google Scholar] 6.Zhao F., Zhou Q., Cong Z., Hang K., Zou X., Zhang C., Chen Y., Dai A., Liang A., Ming Q., et al